Filament Health Corp Market Cap ($1.89 Million)
Market Cap & Net Worth: Filament Health Corp (FH)
Filament Health Corp market cap. Filament Health Corp (NEO:FH) has a market capitalization of $1.89 Million (CA$2.62 Million) as of November 3, 2026. Listed on the NEO stock exchange, this Canada-based company holds position #30113 globally and #1479 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Filament Health Corp's stock price CA$0.01 by its total outstanding shares 261794000 (261.79 Million). Also see Filament Health Corp operating cash flow efficiency for how efficiently the company converts equity into cash flow.
Filament Health Corp Market Cap History (2021–2025)
Filament Health Corp market cap history from 2021 to 2025. Data shows change from $53.03 Million to $1.89 Million (-61.08% CAGR). Check FH stock price for real-time trading data and today's change.
Filament Health Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Filament Health Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Filament Health Corp annual equity growth to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
9.21x
Filament Health Corp's market cap is 9.21 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $53.03 Million | $162.50K | -$9.25 Million | 326.31x | N/A |
| 2022 | $10.42 Million | $364.50K | -$16.47 Million | 28.58x | N/A |
| 2023 | $17.04 Million | $2.13 Million | -$5.32 Million | 8.00x | N/A |
| 2024 | $5.68 Million | $616.68K | -$4.97 Million | 9.21x | N/A |
Competitor Companies of FH by Market Capitalization
Companies near Filament Health Corp in the global market cap rankings as of November 3, 2026. Also see FH total assets for a full breakdown of the balance sheet.
Key companies related to Filament Health Corp by market ranking:
- Melar Acquisition Corp. I Warrant (NASDAQ:MACIW): Ranked #30104 globally with a market cap of $1.91 Million USD.
- Purple Biotech (NASDAQ:PPBT): Ranked #30105 globally with a market cap of $1.90 Million USD.
- Prominence Energy Ltd (AU:PRM): Ranked #30114 globally with a market cap of $1.89 Million USD ( AU$2.68 Million AUD).
- Lifeclean International AB (ST:LCLEAN): Ranked #30115 globally with a market cap of $1.89 Million USD ( Skr17.57 Million SEK).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #30104 | Melar Acquisition Corp. I Warrant | NASDAQ:MACIW | $1.91 Million | $0.12 |
| #30105 | Purple Biotech | NASDAQ:PPBT | $1.90 Million | $1.17 |
| #30114 | Prominence Energy Ltd | AU:PRM | $1.89 Million | AU$0.00 |
| #30115 | Lifeclean International AB | ST:LCLEAN | $1.89 Million | Skr0.02 |
Market Capitalization of Filament Health Corp (2021–2025)
Market capitalization of Filament Health Corp from 2021 to today. Between 2021 and today, Filament Health Corp's market cap moved from $53.03 Million to $ 1.89 Million, with a yearly change of -61.08%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | CA$1.89 Million | -66.67% |
| 2024 | CA$5.68 Million | -66.67% |
| 2023 | CA$17.04 Million | +63.64% |
| 2022 | CA$10.42 Million | -80.36% |
| 2021 | CA$53.03 Million | -- |
End of Day Market Cap According to Different Sources
On May 20th, 2026 the market cap of Filament Health Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.89 Million USD |
| MoneyControl | $1.89 Million USD |
| MarketWatch | $1.89 Million USD |
| marketcap.company | $1.89 Million USD |
| Reuters | $1.89 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Filament Health Corp
Filament Health Corp. operates as a clinical-stage natural psychedelic drug development company in Canada. The company's leading drug candidates comprises PEX010 oral psilocybin, PEX020 oral psilocin, and PEX030 sublingual psilocin. It also develops AEX010 ayahuasca, which is in preclinical stage; and AEX020 monoamine oxidase inhibitor and is in preclinical stage. In addition, the company provide… Read more